• 1
    Pachman LM. Juvenile dermatomyositis: pathophysiology and disease expression. Pediatr Clin North Am 1995; 42: 107198.
  • 2
    Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990; 27: 34356.
  • 3
    Karpati G, Carpenter S. Pathology of the inflammatory myopathies. Baillieres Clin Neurol 1993; 2: 52756.
  • 4
    Adams EM, Chow CK, Premkumar A, Plotz PH. The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics 1995; 15: 56374.
  • 5
    Feldman BM, Ayling-Campos A, Luy L, Stevens D, Silverman ED, Laxer RM. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995; 22: 32631.
  • 6
    Huber AM, Lang B, LeBlanc CMA, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43: 5419.
  • 7
    Josefson A, Romanus E, Carlsson J. A functional index in myositis. J Rheumatol 1996; 23: 13804.
  • 8
    Forte S, Carlone S, Vaccaro F, Onorati P, Manfredi F, Serra P, et al. Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus. J Rheumatol 1999; 26: 25914.
  • 9
    Blom-Bulow B, Jonson B, Bauer K. Factors limiting exercise performance in progressive systemic sclerosis. Semin Arthritis Rheum 1983; 13: 17481.
  • 10
    Beals CA, Lampman RM, Banwell BF, Braunstein EM, Albers JW, Castor CW. Measurement of exercise tolerance in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1985; 12: 45861.
  • 11
    Hebert CA, Byrnes TJ, Baethge BA, Wolf RE, Kinasewitz GT. Exercise limitation in patients with polymyositis. Chest 1990; 98: 3527.
  • 12
    Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, Graninger W. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000; 81: 15.
  • 13
    Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 25586.
  • 14
    Washington RL, Bricker T, Alpert BS, Daniels SR, Deckelbaum RJ, Fisher EA, et al. AHA Guidelines for exercise testing in the pediatric age group. Circulation 1990; 90: 216679.
  • 15
    Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Arthritis Rheum 1997; 40: 197683.
  • 16
    Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy. Arthritis Rheum 2000; 43: 186673.
  • 17
    Kendall FP, Kendall-Mcreary E, Provance PG. Muscles testing and function, with posture and pain. 4th ed. Baltimore (MD): Williams & Wilkins; 1993.
  • 18
    Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al., in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 22139.
  • 19
    Cooper DM, Weiler-Ravell D, Whipp BJ, Wasserman K. Aerobic parameters of exercise as a function of body size during growth in children. J Appl Physiol 1984; 56: 62834.
  • 20
    Rowland TW. Developmental Exercise Physiology. Champaign (IL): Human Kinetics; 1996.
  • 21
    Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 20207.
  • 22
    Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Principles of exercise testing and prescription. Malvern (PA): Lea & Febiger; 1994.
  • 23
    Armitage P. Statistical Methods in Medical Research. New York: John Wiley & Sons; 1971. p. 1269.
  • 24
    Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85: 136473.
  • 25
    Palange P, Forte S, Onorati P, Paravati V, Manfredi F, Serra P, Carlone S. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 1998; 114: 128.
  • 26
    Horber FF, Hoopeler H, Scheidegger JR, Grunig BE, Howald H, Frey FJ. Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids. J Clin Invest 1987; 79: 118190.
  • 27
    Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 2000; 43: 235967.
  • 28
    McBrine JJ, Mazzocca AD, Hayes JC, Roper ML, Barrows LH, Harris BA, et al. Adjusting VO2max for decrements in strength following 7 days of bedrest. Med Sci Sports Exerc 1990; 22: S11.
  • 29
    Saltin B, Blomqvist G, Mitchell JH, Johnson RL, Wildenthal K, Chapman CB. Response to exercise after bedrest and after training. Circulation 1968; 38 (): 5 Suppl VII 178.
  • 30
    Hung J, Goldwater D, Convertino VA, McKillop JH, Goris ML, DeBusk RF. Mechanisms for decreased exercise capacity after bedrest in normal middle-aged men. Am J Cardiol 1983; 51: 5448.
  • 31
    Rowland TW. Effect of prolonged inactivity on aerobic fitness of children. J Sports Med Phys Fitness 1994; 34: 14755.
  • 32
    ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription. 3rd ed. Baltimore (MD): Lippincott, Williams and Wilkins; 1998.
  • 33
    Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF, Paffenbarger RS. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 7180.
  • 34
    Krahenbuhl GS, Williams TJ. Running economy: changes with age during childhood and adolescence. Med Sci Sports Exerc 1992; 24: 4626.
  • 35
    Resnick JS, Mammel M, Mundale MO, Kottke FJ. Muscular strength as an index of response to therapy in childhood dermatomyositis. Arch Phys Med Rehabil 1981; 62: 129.
  • 36
    Wiesinger GF, Quittan M, Aringer M, Seeber A, Volc-Plazer B, Smolen J, et al. Improvement in physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998; 37: 196200.
  • 37
    Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998; 37: 133842.